Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor of Lung”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01499212
What this trial is testing

Effects of Different I:E Ratio on Intrapulmonary Shunt Fraction and Oxygenation During One Lung Ventilation in the Lateral Decubitus Position

Who this might be right for
Lung CancerLung Lobectomy
Yonsei University 58
Testing effectiveness (Phase 2)UnknownNCT06182800
What this trial is testing

Adebrelimab Combined With Bevacizumab and Docetaxel for Advanced Non-Squamous Non-small Cell Lung Cancer After Progression on First-line Immunotherapy

Who this might be right for
Non-small Cell Lung Cancer
The First Affiliated Hospital of Xinxiang Medical College 35
Testing effectiveness (Phase 2)Study completedNCT05253807
What this trial is testing

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Incyte Corporation 8
Testing effectiveness (Phase 2)Study completedNCT00368992
What this trial is testing

S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+5 more
National Cancer Institute (NCI) 110
Large-scale testing (Phase 3)Study completedNCT00982111
What this trial is testing

First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 633
Not applicableStudy completedNCT00867711
What this trial is testing

Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) Patients

Who this might be right for
MALIGNANT PLEURAL MESOTHELIOMA
Istituto Clinico Humanitas 121
Not applicableUnknownNCT05839353
What this trial is testing

Evaluation of the Effect of Training in the Situation Background Assessment Recommendation (SBAR) Tool on the Feeling of Self-efficacy of Carers of Patients With Lung Cancer in the Face of a Situation of Simulated Respiratory Distress.

Who this might be right for
Caregivers
Centre Hospitalier Universitaire de la Réunion 32
Testing effectiveness (Phase 2)Study completedNCT02318277
What this trial is testing

Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203)

Who this might be right for
Solid TumorsHead and Neck CancerLung Cancer+1 more
Incyte Corporation 176
Not applicableStudy completedNCT03725475
What this trial is testing

Reveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer Patients

Who this might be right for
Non-small-cell Lung Cancer (NSCLC)
AstraZeneca 3,111
Testing effectiveness (Phase 2)Study completedNCT00988936
What this trial is testing

Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug

Who this might be right for
Metastatic Breast CancerMetastatic Colon/Rectum CancerNon-squamous Non-small Cell Lung Cancer
Siemens Molecular Imaging 35
Not applicableUnknownNCT05355675
What this trial is testing

The Association of Microbiota Composition With cGVHD After Allo-HSCT

Who this might be right for
Hematopoietic Stem Cell TransplantationHematologic MalignancyChronic Graft-versus-host-disease+1 more
First Affiliated Hospital of Zhejiang University 300
Testing effectiveness (Phase 2)Study completedNCT01533181
What this trial is testing

Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Recurrent Small Cell Lung Carcinoma
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Looking for participantsNCT05498428
What this trial is testing

Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-small-Cell Lung
Janssen Research & Development, LLC 520
Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)Ended earlyNCT02335944
What this trial is testing

Study of Safety and Efficacy of EGFR-TKI EGF816 in Combination With cMET Inhibitor INC280 in Adult Patients With EGFR Mutated Non Small Cell Lung Cancer.

Who this might be right for
Non Small Cell Lung Cancer
Novartis Pharmaceuticals 177
Large-scale testing (Phase 3)Study completedNCT01631357
What this trial is testing

Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer

Who this might be right for
Non-small Cell Lung CancerSquamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 96
Not applicableUnknownNCT04553601
What this trial is testing

Molecular Imaging Visualization of Tumor Heterogeneity in Non-small Cell Lung Cancer

Who this might be right for
NSCLCPET/CTBiopsy+3 more
The First Affiliated Hospital of Xiamen University 150
Early research (Phase 1)Looking for participantsNCT04842812
What this trial is testing

Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors

Who this might be right for
Liver CancerLung CancerBreast Cancer+5 more
Second Affiliated Hospital of Guangzhou Medical University 40
Early research (Phase 1)Study completedNCT01324492
What this trial is testing

Safety and Efficacy of RAD001 in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor

Who this might be right for
Lung Neuroendocrine Neoplasm
Novartis Pharmaceuticals 16
Early research (Phase 1)Not Yet RecruitingNCT07650357
What this trial is testing

CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)

Who this might be right for
Advanced Solid TumorNon Small Cell Lung CancerPancreatic Carcinoma+1 more
Clasp Therapeutics, Inc. 140
Next Page